Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer

Journal of Applied Genetics

Volumn 56, Issue 2, 2015, Pages 185-192

  Szmida, Elzbieta ^a   Karpiński, Pawel ^a   Leszczynski, Przemyslaw ^a   Sedziak, Tomasz ^b   Kielan, Wojciech ^a   Ostasiewicz, Paweł ^a   Sasiadek, Maria M ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Wroclaw   (Poland)

Author keywords

Colorectal; ERBB; Illumina 27k; Methylation; PKCB

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 4; ERBB4 PROTEIN, HUMAN; P21 ACTIVATED KINASE; PAK7 PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PIK3CD PROTEIN, HUMAN; PROTEIN KINASE C BETA;

ADULT; AGED; COLORECTAL TUMOR; CPG ISLAND; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HUMAN; MALE; MIDDLE AGED; PROTO ONCOGENE; SIGNAL TRANSDUCTION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CLASS I PHOSPHATIDYLINOSITOL 3-KINASES; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB; HUMANS; MALE; MIDDLE AGED; P21-ACTIVATED KINASES; PROTEIN KINASE C BETA; RECEPTOR, ERBB-4; SIGNAL TRANSDUCTION;

EID: 84939954290     PISSN: 12341983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13353-014-0253-6     Document Type: Article

References (40)

1. Andrulis IL, Bull SB, Blackstein ME, Sutherland D, Mak C, Sidlofsky S, Pritzker KPH, Hartwick RW, Hanna W, Lickley L, Wilkinson R, Qizilbash A, Ambus U, Lipa M, Weizel H, Katz A, Baida M, Mariz S, Stoik G, Dacamara P, Strongitharm D, Geddie W, McCready D (1998) neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group. J Clin Oncol 16:1340–1349
2. Blazejczyk M, Miron M, Nadon R (2007) FlexArray: a statistical data analysis software for gene expression microarrays. Genome Quebec, Montreal, Canada
3. Buhard O, Cattaneo F, Wong YF, Yim SF, Friedman E, Flejou JF, Duval A, Hamelin R (2006) Multipopulation analysis of polymorphisms in five mononucleotide repeats used to determine the microsatellite instability status of human tumors. J Clin Oncol 24:241–251
4. Das PM, Thor AD, Edgerton SM, Barry SK, Chen DF, Jones FE (2010) Reactivation of epigenetically silenced HER4/ERBB4 results in apoptosis of breast tumor cells. Oncogene 29:5214–5219
5. Engelman JA, Zejnullahu K, Gale C-M, Lifshits E, Gonzales AJ, Shimamura T, Zhao F, Vincent PW, Naumov GN, Bradner JE, Althaus IW, Gandhi L, Shapiro GI, Nelson JM, Heymach JV, Meyerson M, Wong K-K, Jänne PA (2007) PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib. Cancer Res 67:11924–11932
6. Enroth S, Rada-Iglesisas A, Andersson R, Wallerman O, Wanders A, Påhlman L, Komorowski J, Wadelius C (2011) Cancer associated epigenetic transitions identified by genome-wide histone methylation binding profiles in human colorectal cancer samples and paired normal mucosa. BMC Cancer 11:450
7. Fellows I (2012) Deducer: a data analysis GUI for R. J Stat Softw 49:1–15
8. Furnari MA, Jobes ML, Nekrasova T, Minden A, Wagner GC (2013) Functional deficits in pak5, pak6 and pak5/pak6 knockout mice. PLoS One 8:e61321
9. Glimelius B, Lahn M, Gawande S, Cleverly A, Darstein C, Musib L, Liu Y, Spindler KL, Frödin JE, Berglund A, Byström P, Qvortrup C, Jakobsen A, Pfeiffer P (2010) A window of opportunity phase II study of enzastaurin in chemonaive patients with asymptomatic metastatic colorectal cancer. Ann Oncol 21:1020–1026
10. Gökmen-Polar Y, Murray NR, Velasco MA, Gatalica Z, Fields AP (2001) Elevated protein kinase C betaII is an early promotive event in colon carcinogenesis. Cancer Res 61:1375–1381
11. Gong W, An Z, Wang Y, Pan X, Fang W, Jiang B, Zhang H (2009) P21-activated kinase 5 is overexpressed during colorectal cancer progression and regulates colorectal carcinoma cell adhesion and migration. Int J Cancer 125:548–555
12. Graff JR, McNulty AM, Hanna KR, Konicek BW, Lynch RL, Bailey SN, Banks C, Capen A, Goode R, Lewis JE, Sams L, Huss KL, Campbell RM, Iversen PW, Neubauer BL, Brown TJ, Musib L, Geeganage S, Thornton D (2005) The protein kinase Cbeta-selective inhibitor, Enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts. Cancer Res 65:7462–7469
13. Gu J, Li K, Li M, Wu X, Zhang L, Ding Q, Wu W, Yang J, Mu J, Wen H, Ding Q, Lu J, Hao Y, Chen L, Zhang W, Li S, Liu Y (2013) A role for p21-activated kinase 7 in the development of gastric cancer. FEBS J 280:46–55
14. Hagiwara K, Ito H, Murate T, Miyata Y, Ohashi H, Nagai H (2012) PROX1 overexpression inhibits protein kinase C beta II transcription through promoter DNA methylation. Genes Chromosomes Cancer 51:1024–1036
15. Hinoue T, Weisenberger DJ, Lange CP, Shen H, Byun HM, Van Den Berg D, Malik S, Pan F, Noushmehr H, van Dijk CM, Tollenaar RA, Laird PW (2012) Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res 22:271–282
16. Hoque MO, Brait M, Rosenbaum E, Poeta ML, Pal P, Begum S, Dasgupta S, Carvalho AL, Ahrendt SA, Westra WH, Sidransky D (2010) Genetic and epigenetic analysis of erbB signaling pathway genes in lung cancer. J Thorac Oncol 5:1887–1893
17. Karpinski P, Szmida E, Misiak B, Ramsey D, Leszczynski P, Bebenek M, Sedziak T, Grzebieniak Z, Jonkisz A, Lebioda A, Sasiadek MM (2012) Assessment of three epigenotypes in colorectal cancer by combined bisulfite restriction analysis. Mol Carcinog 51:1003–1008
18. Kilaru V, Barfield RT, Schroeder JW, Smith AK, Conneely KN (2012) MethLAB: a graphical user interface package for the analysis of array-based DNA methylation data. Epigenetics 7:225–229
19. Kok K, Nock GE, Verrall EA, Mitchell MP, Hommes DW, Peppelenbosch MP, Vanhaesebroeck B (2009) Regulation of p110delta PI 3-kinase gene expression. PLoS One 4:e5145
20. Kouzarides T (2007) Chromatin modifications and their function. Cell 128:693–705
21. Laczmanska I, Karpinski P, Bebenek M, Sedziak T, Ramsey D, Szmida E, Sasiadek MM (2013) Protein tyrosine phosphatase receptor-like genes are frequently hypermethylated in sporadic colorectal cancer. J Hum Genet 58:11–15
22. Lemmon MA, Schlessinger J (2010) Cell signaling by receptor tyrosine kinases. Cell 141:1117–1134
23. Miranda E, Destro A, Malesci A, Balladore E, Bianchi P, Baryshnikova E, Franchi G, Morenghi E, Laghi L, Gennari L, Roncalli M (2006) Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer. Br J Cancer 95:1101–1107
24. Montero AJ, Marcela Díaz-Montero C, Mao L, Youssef EM, Estecio M, Shen L, Issa J-PJ (2006) Epigenetic inactivation of EGFR by CpG island hypermethylation in cancer. Cancer Biol Ther 5:1494–1501
25. Petrangeli E, Lubrano C, Ravenna L, Vacca A, Cardillo MR, Salvatori L, Sciarra F, Frati L, Gulino A (1995) Gene methylation of oestrogen and epidermal growth factor receptors in neoplastic and perineoplastic breast tissues. Br J Cancer 72:973–975
26. Razin A, Cedar H (1991) DNA methylation and gene expression. Microbiol Rev 55:451–458
27. Sapio MR, Posca D, Troncone G, Pettinato G, Palombini L, Rossi G, Fenzi G, Vitale M (2006) Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA). Eur J Endocrinol 154:341–348
28. Sauter G, Moch H, Moore D, Carroll P, Kerschmann R, Chew K, Mihatsch MJ, Gudat F, Waldman F (1993) Heterogeneity of erbB-2 gene amplification in bladder cancer. Cancer Res 53:2199–2203
29. Sawyer C, Sturge J, Bennett DC, O’Hare MJ, Allen WE, Bain J, Jones GE, Vanhaesebroeck B (2003) Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110delta. Cancer Res 63:1667–1675
30. Scartozzi M, Bearzi I, Mandolesi A, Giampieri R, Faloppi L, Galizia E, Loupakis F, Zaniboni A, Zorzi F, Biscotti T, Labianca R, Falcone A, Cascinu S (2011) Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients. Br J Cancer 104:1786–1790
31. Skog M, Bono P, Lundin M, Lundin J, Louhimo J, Linder N, Petrova TV, Andersson LC, Joensuu H, Alitalo K, Haglund CH (2011) Expression and prognostic value of transcription factor PROX1 in colorectal cancer. Br J Cancer 105:1346–1351
32. Spalding AC, Zeitlin BD, Wilder-Romans K, Davis ME, Nor JE, Lawrence TS, Ben-Josef E (2008) Enzastaurin, an inhibitor of PKCbeta, enhances antiangiogenic effects and cytotoxicity of radiation against endothelial cells. Transl Oncol 1:195–201
33. Sproul D, Kitchen RR, Nestor CE, Dixon JM, Sims AH, Harrison DJ, Ramsahoye BH, Meehan RR (2012) Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns. Genome Biol 13:R84
34. Tzenaki N, Papakonstanti EA (2013) p110δ PI3 kinase pathway: emerging roles in cancer. Front Oncol 3:40
35. van Vlodrop IJ, Niessen HE, Derks S, Baldewijns MM, van Criekinge W, Herman JG, van Engeland M (2011) Analysis of promoter CpG island hypermethylation in cancer: location, location, location! Clin Cancer Res 17:4225–4231
36. Wu WKK, Tse TTM, Sung JJY, Li ZJ, Yu L, Cho CH (2009) Expression of ErbB receptors and their cognate ligands in gastric and colon cancer cell lines. Anticancer Res 29:229–234
37. Xu Y, Hu B, Choi AJ, Gopalan B, Lee BH, Kalady MF, Church JM, Ting AH (2012) Unique DNA methylome profiles in CpG island methylator phenotype colon cancers. Genome Res 22:283–291
38. Yagi K, Akagi K, Hayashi H, Nagae G, Tsuji S, Isagawa T, Midorikawa Y, Nishimura Y, Sakamoto H, Seto Y, Aburatani H, Kaneda A (2010) Three DNA methylation epigenotypes in human colorectal cancer. Clin Cancer Res 16:21–33
39. Yarden Y, Sliwkowski MX (2001) Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2:127–137
40. Zhang H, Berezov A, Wang Q, Zhang G, Drebin J, Murali R, Greene MI (2007) ErbB receptors: from oncogenes to targeted cancer therapies. J Clin Invest 117:2051–2058